FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Heritage Pharmaceuticals Desipramine Hydrochloride Tablets Recall

Desipramine Hydrochloride Tablets, USP, 75 mg, 100 count bottle (NDC 23155-581-01), Rx…

Heritage Pharmaceuticals Inc · East Brunswick, NJ

Risk level
Class II
Reported by FDA
Nov 5, 2025
Recall ID
D-0110-2026
Check your lot numberHow we source this data

Summary

Heritage Pharmaceuticals recalled Desipramine Hydrochloride Tablets starting Oct 6, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0110-2026 on Nov 5, 2025. Reason: CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level. Status: Ongoing.

Why it was recalled

CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.

Product description

Desipramine Hydrochloride Tablets, USP, 75 mg, 100 count bottle (NDC 23155-581-01), Rx only, Manufactured by: USV Private Limited, Daman, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816.

Lot numbers, UPCs & expiration codes

Lot#: 18036662, Exp. Date: 07/31/2026 Lot#: 18037649, Exp. Date: 03/31/2027

Where it was sold

U.S. Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0110-2026
Classification
Class II
Status
Ongoing
Recall initiated
Oct 6, 2025
FDA report date
Nov 5, 2025
Quantity
2,418 bottles.
Recall type
Voluntary: Firm initiated
Recalling firm
Heritage Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0110-2026, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Ongoing
Country
United States
Event ID
97770
Address
1 Tower Center Blvd Ste 1700
Code information
Lot#: 18036662, Exp. Date: 07/31/2026 Lot#: 18037649, Exp. Date: 03/31/2027
Postal code
08816-1145
Report date
Nov 5, 2025
Product type
Drugs
Recall number
D-0110-2026
Classification
Class II
Recalling firm
Heritage Pharmaceuticals Inc
Product quantity
2,418 bottles.
Reason for recall
CGMP Deviations: N-Nitroso Desipramine impurity exceeding the permissible acceptable daily intake level.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Desipramine Hydrochloride Tablets, USP, 75 mg, 100 count bottle (NDC 23155-581-01), Rx only, Manufactured by: USV Private Limited, Daman, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816.
Distribution pattern
U.S. Nationwide.
Recall initiation date
Oct 6, 2025
Initial firm notification
Letter
Center classification date
Oct 27, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0110-2026, published Nov 5, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls